(Q31125310)

29 June 2017

1 reference

title

Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies (English)

1 reference

29 June 2017

1 reference

Sobczak S

1

1 reference

29 June 2017

Honig A

series ordinal

2

1 reference

29 June 2017

van Duinen MA

series ordinal

3

1 reference

29 June 2017

Riedel WJ

series ordinal

4

1 reference

29 June 2017

publication date

1 December 2002

1 reference

29 June 2017

1 reference

29 June 2017

volume

4

1 reference

29 June 2017

issue

6

1 reference

29 June 2017

page(s)

347-356

1 reference

Increased plasma prolactin levels induced in rats by d-fenfluramine: Relation to central serotonergic stimulation

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effect of fenfluramine on mood: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neurobiology of an anorectic drug: fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Prolactin and cortisol responses to fenfluramine challenge in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Hormone responses to fenfluramine and placebo challenge in endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Hormonal probes of central serotonergic activity: do they really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Serotonin release estimated by transcortical dialysis in freely-moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neuroendocrine markers of serotonin responsivity in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Acute tryptophan depletion in bipolar disorders; literature review and directives for further research

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Association Between the Tryptophan Hydroxylase Gene and Manic-depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

The citalopram challenge test in patients with major depression and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Peripheral hormonal responses to D -fenfluramine as a probe of central serotonergic function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Primary structure of the serotonin transporter in unipolar depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Postsynaptic serotonergic activity in depressive patients: evaluation of the neuroendocrine strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Buspirone induced prolactin release in mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Cortisol, Hypothermic, and Behavioral Responses to Ipsapirone in Patients with Bipolar Depression and Normal Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

The influence of cortisol on spontaneous and 5HT stimulated prolactin release in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Familial correlates of reduced central serotonergic system function in patients with personality disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Effects of acute tryptophan depletion in lithium-remitted manic patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Involvement of growth hormone (GH)-releasing factor in GH secretion induced by serotoninergic mechanisms in conscious rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Effect of Intraventricular Injection of Dopamine, Norepinephrine, Acetylcholine, and 5-Hydroxytryptamine on Immunoreactive Somatostatin Release into Rat Hypophyseal Portal Blood*

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Increased platelet serotonin in bipolar depression and hypomania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Serotoninergic Dysfunction in Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Lithium and serotonin function: implications for the serotonin hypothesis of depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Central Serotoninergic Stimulation by Fenfluramine Challenge Does Not Affect Plasma Thyrotropin-Stimulating Hormone Levels in Man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

The influence of fenfluramine stimulation on prolactin plasma levels in lithium long-term-treated manic-depressive patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Hormonal responses to fenfluramine in depressive subtypes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

5-HT1A receptor-effector system responsivity in panic disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Prolactin response to fenfluramine and suicide attempt lethality in major depression.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

d-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01217.X

7 January 2021

10.1034/J.1399-5618.2002.01217.X

Identifiers

DOI

1 reference

29 June 2017

1 reference